Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures
Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms
Read More 5 minute read Healthcare Industry News Technology News FDA clears Stereotaxis GenesisX robotic system, paving way for next-gen precision in cardiac procedures Discover how Stereotaxis’ GenesisX robotic system gained FDA approval and what it means for the future of cardiac robotics. bySoujanya RaviNovember 12, 2025